IL17RB and pancreatic neoplasm: Furthermore, the size and number of the pancreatic tumor spheres were significantly reduced after anti-IL-17RB (D9) treatment, indicating that targeting-IL-17RB could inhibit cancer stemness activity (Fig. 4D).